Absci ABSI
NASDAQ ABSI
$10.17 +0.78 (+8.31%)
At close: Nov 6, 2026 · 4:00 PM EST

Absci (ABSI) Non-Current Deferred Revenue (2021 - 2026)

Updated

Absci (ABSI) recorded Non-Current Deffered Revenue of $240,000 in Q2 2026, down 62.6% from the prior quarter.

Analysis

Absci (ABSI) Non-Current Deferred Revenue (2021 - 2026) Analysis & Trends

At the end of FY2025, Absci reported Non-Current Deffered Revenue of $436,000.

  • Across earlier years, Non-Current Deffered Revenue came in at $966,000 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Absci 1.61 Bn 984.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240,000.00
Mar 31, 2026 641,000.00
Dec 31, 2025 436,000.00
Mar 31, 2024 180,000.00
Dec 31, 2023 966,000.00
Sep 30, 2021 122,000.00
Jun 30, 2021 839,000.00
API Access

Absci Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ABSI&period=max&api_key=YOUR_API_KEY